Investments
1About Trinity Innovation Bioventure Singapore
Trinity Innovation Bioventure Singapore is a licensed biomed venture capital fund focusing on innovation and value investment with deep insight and experience on Asia markets.
Want to inform investors similar to Trinity Innovation Bioventure Singapore about your company?
Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.
Trinity Innovation Bioventure Singapore Investments
1 Investments
Trinity Innovation Bioventure Singapore has made 1 investments. Their latest investment was in Axcynsis Therapeutics as part of their Seed VC on May 5, 2022.
Trinity Innovation Bioventure Singapore Investments Activity
Date | Round | Company | Amount | New? | Co-Investors | Sources |
|---|---|---|---|---|---|---|
5/6/2022 | Seed VC | Axcynsis Therapeutics | $15M | Yes | Trinity Innovation Bioventure Singapore, and Undisclosed Investors | 1 |
Date | 5/6/2022 |
|---|---|
Round | Seed VC |
Company | Axcynsis Therapeutics |
Amount | $15M |
New? | Yes |
Co-Investors | Trinity Innovation Bioventure Singapore, and Undisclosed Investors |
Sources | 1 |
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.